Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics. (Q55461129)

12 July 2018

title

Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics. (English)

1 reference

12 July 2018

0 references

Jun Liang

1 reference

12 July 2018

Xianli Zhang

1 reference

12 July 2018

Shao Xie

1 reference

12 July 2018

Xiuping Zhou

1 reference

12 July 2018

Qiong Shi

1 reference

12 July 2018

Jinxia Hu

1 reference

12 July 2018

Weifeng Wang

1 reference

12 July 2018

Weifeng Qi

1 reference

12 July 2018

Rutong Yu

1 reference

12 July 2018

publication date

27 February 2014

1 reference

12 July 2018

published in

Medical Oncology

1 reference

12 July 2018

volume

1 reference

12 July 2018

issue

1 reference

12 July 2018

page(s)

899

1 reference

12 July 2018

Primary brain tumours in adults.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Gliomagenesis: genetic alterations and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Targeting the ubiquitin system in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

The expression patterns of deubiquitinating enzymes, USP22 and Usp22

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Increased expression of ubiquitin‐specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

The ubiquitin hydrolase USP22 contributes to 3'-end processing of JAK-STAT-inducible genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

The Bmi-1/NF-κB/VEGF story: another hint for proteasome involvement in glioma angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Bmi-1 promotes glioma angiogenesis by activating NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0899-2

Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1.

21 January 2018

1 reference

12 December 2020

RNA interference-mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest

1 reference

12 December 2020

The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy

1 reference

12 December 2020

Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest.

1 reference

12 December 2020

The Co-expression of USP22 and BMI-1 May Promote Cancer Progression and Predict Therapy Failure in Gastric Carcinoma

1 reference

12 December 2020

Implication of USP22 in the Regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and Cyclin D2 Expression in Primary Colorectal Carcinomas

1 reference

12 December 2020

Elderly and poor prognosis patients with high grade glioma: hypofractionated radiotherapy.

1 reference

12 December 2020

10.1007/S12032-014-0899-2

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

1002747829

0 references

1 reference

12 July 2018